Clinical Trial

Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus

Name: Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus — clinical trial record (NCT07187856)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Trial Details

NCT Number	NCT07187856
Lead Sponsor	ProGen. Co., Ltd.
Conditions	Type 2 Diabetes Mellitus (T2DM)
Enrollment	80 participants
Start Date	2026-01
Primary Completion	2026-09 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2025-09-23